Protara Therapeutics, Inc. Stock-Based Compensation
Protara Therapeutics, Inc. (TARA) reported Stock-Based Compensation of $1.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- Protara Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.38M, a 53.27% increase year-over-year.
- Protara Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.36M, a 63.51% increase year-over-year.
- Protara Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.04M, a 15.38% increase year-over-year.
- Protara Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.05M, a 12.46% increase year-over-year.
- Protara Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $3.83M, a 7.25% decline from fiscal 2024.
- Protara Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $4.13M, a 32.29% decline from fiscal 2023.
- Protara Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $6.09M, a 8.91% decline from fiscal 2022.
- Protara Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $6.69M, a 35.46% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.38M 10-Q · filed 2026-08-11 | $2.75M 10-Q · filed 2026-08-11 | $3.79M derived: sum of 3 quarters · filed 2026-08-11 | $4.84M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $1.36M 10-Q · filed 2026-05-13 | $2.40M derived: sum of 2 quarters · filed 2026-05-13 | $3.45M derived: sum of 3 quarters · filed 2026-05-13 | $4.36M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.09M derived: sum of 2 quarters · filed 2026-03-10 | $2.99M derived: sum of 3 quarters · filed 2026-08-11 | $3.83M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $1.05M 10-Q · filed 2025-11-10 | $1.95M derived: sum of 2 quarters · filed 2026-08-11 | $2.78M 10-Q · filed 2025-11-10 | $3.69M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $903.00K 10-Q · filed 2026-08-11 | $1.74M 10-Q · filed 2026-08-11 | $2.64M derived: sum of 3 quarters · filed 2026-08-11 | $3.57M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $833.00K 10-Q · filed 2026-05-13 | $1.74M derived: sum of 2 quarters · filed 2026-05-13 | $2.67M derived: sum of 3 quarters · filed 2026-05-13 | $3.73M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $904.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.83M derived: sum of 2 quarters · filed 2026-03-10 | $2.90M derived: sum of 3 quarters · filed 2026-03-10 | $4.13M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $931.00K 10-Q · filed 2025-11-10 | $2.00M derived: sum of 2 quarters · filed 2025-11-10 | $3.22M 10-Q · filed 2025-11-10 | $4.67M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $1.06M 10-Q · filed 2025-08-11 | $2.29M 10-Q · filed 2025-08-11 | $3.74M derived: sum of 3 quarters · filed 2025-08-11 | $5.19M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $1.23M 10-Q · filed 2025-05-08 | $2.68M derived: sum of 2 quarters · filed 2025-05-08 | $4.13M derived: sum of 3 quarters · filed 2025-05-08 | $5.74M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $2.90M derived: sum of 2 quarters · filed 2025-03-05 | $4.52M derived: sum of 3 quarters · filed 2025-03-05 | $6.09M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.06M derived: sum of 2 quarters · filed 2024-11-12 | $4.64M 10-Q · filed 2024-11-12 | $6.07M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $3.19M 10-Q · filed 2024-08-06 | $4.62M derived: sum of 3 quarters · filed 2024-08-06 | $6.06M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $1.57M 10-Q · filed 2024-05-02 | $3.00M derived: sum of 2 quarters · filed 2024-05-02 | $4.44M derived: sum of 3 quarters · filed 2024-05-02 | $6.38M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.87M derived: sum of 2 quarters · filed 2024-03-13 | $4.81M derived: sum of 3 quarters · filed 2024-03-13 | $6.69M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $1.44M 10-Q · filed 2022-11-03 | $3.38M derived: sum of 2 quarters · filed 2022-11-03 | $5.26M 10-Q · filed 2023-11-03 | $7.17M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2022-06-30 | $1.94M 10-Q · filed 2022-08-09 | $3.82M 10-Q · filed 2023-08-03 | $5.73M derived: sum of 3 quarters · filed 2023-05-04 | $8.45M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2022-03-31 | $1.88M 10-Q · filed 2023-05-04 | $3.79M derived: sum of 2 quarters · filed 2023-05-04 | $6.50M derived: sum of 3 quarters · filed 2023-05-04 | $9.50M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $4.62M derived: sum of 2 quarters · filed 2023-03-08 | $7.62M derived: sum of 3 quarters · filed 2023-03-08 | $10.36M 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | $2.72M 10-Q · filed 2022-11-03 | $5.71M derived: sum of 2 quarters · filed 2022-11-03 | $8.45M 10-Q · filed 2022-11-03 | $10.79M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $3.00M 10-Q · filed 2022-08-09 | $5.74M 10-Q · filed 2022-08-09 | $8.08M derived: sum of 3 quarters · filed 2022-08-09 | $10.86M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $2.74M 10-Q · filed 2022-05-05 | $5.08M derived: sum of 2 quarters · filed 2022-05-05 | $7.86M derived: sum of 3 quarters · filed 2022-05-05 | $9.69M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $5.12M derived: sum of 2 quarters · filed 2022-03-09 | $6.95M derived: sum of 3 quarters · filed 2022-03-09 | $9.75M 10-K · filed 2022-03-09 | ||||
| 2020-09-30 | $2.78M 10-Q · filed 2021-11-04 | $2.78M 10-Q · filed 2020-11-12 | $4.61M derived: sum of 2 quarters · filed 2021-11-04 | $7.41M 10-Q · filed 2021-11-04 | $7.41M 10-Q · filed 2020-11-12 | $7.51M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $1.83M 10-Q · filed 2021-08-05 | $1.83M 10-Q · filed 2020-07-31 | $4.63M 10-Q · filed 2021-08-05 | $4.63M 10-Q · filed 2020-07-31 | $4.73M derived: sum of 3 quarters · filed 2021-08-05 | $4.87M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $2.80M 10-Q · filed 2021-05-06 | $2.80M 10-Q · filed 2020-05-13 | $2.90M derived: sum of 2 quarters · filed 2021-05-06 | $3.04M derived: sum of 3 quarters · filed 2021-05-06 | $3.15M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $105.52K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $244.66K derived: sum of 2 quarters · filed 2021-03-11 | $347.12K derived: sum of 3 quarters · filed 2021-03-11 | $424.00K 10-K · filed 2021-03-11 | $943.00K 10-K · filed 2020-03-20 | |||
| 2019-09-30 | $139.14K 10-Q · filed 2020-11-12 | $241.60K derived: sum of 2 quarters · filed 2020-11-12 | $318.48K 10-Q · filed 2020-11-12 | $977.00K 10-Q · filed 2019-10-31 | $1.10M derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | $102.46K 10-Q · filed 2020-07-31 | $179.34K 10-Q · filed 2020-07-31 | $881.00K 10-Q · filed 2019-08-07 | $961.34K derived: sum of 3 quarters · filed 2020-07-31 | $1.87M derived: sum of 4 quarters · filed 2020-07-31 | |||
| 2019-03-31 | $76.88K 10-Q · filed 2020-05-13 | $780.00K 10-Q · filed 2019-05-08 | $858.88K derived: sum of 2 quarters · filed 2020-05-13 | $1.76M derived: sum of 3 quarters · filed 2020-05-13 | $2.68M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | $782.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $1.69M derived: sum of 2 quarters · filed 2020-03-20 | $2.61M derived: sum of 3 quarters · filed 2020-03-20 | $3.43M 10-K · filed 2020-03-20 | ||||
| 2018-09-30 | $904.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $1.83M derived: sum of 2 quarters · filed 2019-10-31 | $2.65M 10-Q · filed 2019-10-31 | $3.42M derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | $922.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.74M 10-Q · filed 2019-08-07 | $2.51M derived: sum of 3 quarters · filed 2019-08-07 | $3.26M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $821.00K 10-Q · filed 2019-05-08 | $1.59M derived: sum of 2 quarters · filed 2019-05-08 | $2.34M derived: sum of 3 quarters · filed 2019-05-08 | $3.20M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $1.51M derived: sum of 2 quarters · filed 2019-03-13 | $2.38M derived: sum of 3 quarters · filed 2019-03-13 | $3.23M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $747.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.61M derived: sum of 2 quarters · filed 2018-11-07 | $2.46M 10-Q · filed 2018-11-07 | $3.30M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | $867.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.71M 10-Q · filed 2018-08-07 | $2.56M derived: sum of 3 quarters · filed 2019-03-13 | $3.24M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | $845.00K 10-Q · filed 2018-05-09 | $1.69M derived: sum of 2 quarters · filed 2019-03-13 | $2.38M derived: sum of 3 quarters · filed 2019-03-13 | $3.32M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | $844.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $1.53M derived: sum of 2 quarters · filed 2019-03-13 | $2.48M derived: sum of 3 quarters · filed 2019-03-13 | $3.34M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $687.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.63M derived: sum of 2 quarters · filed 2017-11-07 | $2.50M 10-Q · filed 2017-11-07 | $3.17M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-06-30 | $946.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.81M 10-Q · filed 2017-08-07 | $2.48M derived: sum of 3 quarters · filed 2018-03-14 | $3.09M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-03-31 | $866.00K 10-Q · filed 2017-05-10 | $1.54M derived: sum of 2 quarters · filed 2018-03-14 | $2.15M derived: sum of 3 quarters · filed 2018-03-14 | $2.62M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2015-12-31 | $670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.28M derived: sum of 2 quarters · filed 2018-03-14 | $1.76M derived: sum of 3 quarters · filed 2018-03-14 | $2.16M 10-K · filed 2018-03-14 | ||||
| 2015-09-30 | $611.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.09M derived: sum of 2 quarters · filed 2016-11-07 | $1.49M 10-Q · filed 2016-11-07 | $1.72M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $476.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $883.00K 10-Q · filed 2016-08-08 | $1.11M derived: sum of 3 quarters · filed 2017-03-16 | $1.29M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $407.00K 10-Q · filed 2016-05-09 | $632.00K derived: sum of 2 quarters · filed 2017-03-16 | $817.00K derived: sum of 3 quarters · filed 2017-03-16 | $849.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $410.00K derived: sum of 2 quarters · filed 2017-03-16 | $442.00K derived: sum of 3 quarters · filed 2017-03-16 | $459.00K 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $217.00K derived: sum of 2 quarters · filed 2015-11-12 | $234.00K 10-Q · filed 2015-11-12 | $263.00K derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $49.00K 10-Q · filed 2015-08-13 | $78.00K derived: sum of 3 quarters · filed 2016-03-14 | |||||
| 2014-03-31 | $17.00K 10-Q · filed 2015-05-13 | $46.00K derived: sum of 2 quarters · filed 2016-03-14 | ||||||
| 2013-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $155.00K 10-K · filed 2016-03-14 | ||||||
| 2013-09-30 | $126.00K 10-Q · filed 2014-11-25 | |||||||
| 2012-12-31 | $110.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |